Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    EWDr. Ethel Weld

    Dr. Ethel Weld

    Infectious Disease · HIV & AIDS Medicine
    Johns Hopkins Medicine
    ethelw

    Research

    Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing

    2026

    Via AIDS (London, England)

    Research

    Curated Cases from the TB Expert Network: Unplugged!: Navigating Uncertainty in Treatment of a Child with Multidrug-Resistant Tuberculosis

    2026

    Via Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

    Research

    Advancing Maternal Health with Long-Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

    2026

    Via Clinical Pharmacology and Therapeutics

    Research

    A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

    2026

    Via Clinical Pharmacology and Therapeutics

    Oct 28, 2026Journal Article

    Long-Acting Antiretroviral Therapy to Treat Advanced HIV in Pregnancy: Let Not Delayed Detection Be the Enemy of the Good.

    ​

    Written by 1 Roon author & 1 other

    Via Clinical Infectious Diseases

    Research

    5' leader defects drive persistent HIV-1 viremia on long-term ART

    2026

    Via Nature Communications

    Research

    Investigations of Long-Acting Formulations in Children, Adolescents, and Pregnant Women: A Systematic Review

    2025

    Via Pharmaceutics

    Research

    Acceptability of a rectal microbicide douche for HIV prevention: a mixed-methods analysis of a first-in-human formulation pilot study

    2025

    Via Sexually Transmitted Infections

    Research

    Exploring Preferences, Concerns, and Implementation of Different Long-Acting Antiretroviral Strategies for Youth with HIV Facing Adherence Challenges

    2025

    Via AIDS Patient Care and STDs

    Research

    Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

    2025

    Via The Lancet HIV

    Research

    Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

    2024

    Via The Journal of Infectious Diseases

    Research

    Mapping Colorectal Distribution of Cell-free and Cell-associated HIV Surrogates Following Simulated Anal Intercourse to Aid Rectal Microbicide Development

    2024

    Via Journal of Acquired Immune Deficiency Syndromes

    Research

    Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers

    2024

    Via Journal of Viral Hepatitis

    Research

    Pharmacokinetics of tenofovir alafenamide, emtricitabine, and dolutegravir in a patient on peritoneal dialysis

    2024

    Via AIDS Research and Therapy

    Research

    Strategic use of salvage long-acting antiretrovirals in the setting of resistance

    2024

    Via American Journal of Health-System Pharmacy